
More than 60% of cases reviewed through the system are now closed within three days.
| Photo Credit: Reuters
Apollo Hospitals has developed an artificial intelligence (AI) agent in collaboration with Microsoft to help clinicians identify patient safety risks, investigate adverse events and strengthen clinical governance across its hospital network.
Called the Daily Tiered Huddle (DTH) agent, the system was developed by Microsoft’s forward-deployed engineers (FDEs) working alongside Apollo’s doctors and technology teams. Instead of building a standalone product, the engineers embedded themselves in Apollo’s clinical governance processes to understand how doctors assess safety incidents and develop an AI solution around their requirements.
According to a Microsoft report, Apollo’s clinical governance team reviews approximately 600 adverse events every month across its 55 main hospitals. These include patient falls, medication errors and readmissions.
The AI agent consolidates relevant patient information, including treatment timelines, medication records and blood test results, to help clinicians evaluate incidents. It flags cases for review, summarises patient records and recommends questions and assessments for doctors.
Apollo’s Chief of Medical Services, Dr. Rohini Sridhar, said more than 60% of cases reviewed through the system are now closed within three days. The improvement, the hospital said, reflects the agent’s ability to prepare cases for clinical assessment, allowing doctors to focus on complex investigations.
The system also identifies incidents requiring deeper examination through clinical outcomes and quality review (COQR) and root cause analysis (RCA).

Designed as a continuous learning system, the agent incorporates discussions and decisions from daily clinical reviews into an organisational knowledge base, refining its subsequent questions and assessments. It was developed using Microsoft Foundry and Microsoft Fabric, with Microsoft Work IQ providing organisational context.
Clinicians retain control over the review process and can modify the agent’s recommendations. Microsoft said synthetic data, rather than Apollo’s electronic health records, was used for development evaluations and testing.
The system has also helped identify patterns that might otherwise escape detection. Microsoft cited a cluster of central line-associated bloodstream infections in a bone marrow transplant unit that prompted corrective action.
Apollo reported a decline in patient falls and medication errors between July and September 2026 against the corresponding period in 2025. Its annual safety culture survey also indicated an almost 30% improvement in staff satisfaction with the handling of errors.
Apollo CIO Ashokkan Somuveerappan described the collaboration with Microsoft’s engineers as a different and innovative approach to technology development.
Published – November 18, 2026 03:41 pm IST
Leave a Reply